Latest Industrial Growth News

Page 1 of 9
Entergy delivered a sharp rise in third-quarter earnings, while narrowing its 2026 adjusted EPS guidance and raising its quarterly dividend. Stronger electricity sales, regulatory recovery and construction-related returns drove the result, although rising debt and capital spending remain part of the equation.
Maxwell Dee
Maxwell Dee
3 Nov 2026
EMVision Medical Devices has taken its pivotal emu™ trial beyond 230 participants while preparing to add acute ischaemic stroke detection to the FDA validation program. The ASX-listed medtech ended September with $18.1 million in cash and $3.7 million in remaining grant funding.
Victor Sage
Victor Sage
26 Oct 2026
Iondrive received $3.765 million in grant cash during FY2026, including $3.691 million from the Australian Government’s Industry Growth Program. The company has deferred $1.671 million of that funding until further eligible pilot plant expenditure is incurred.
Victor Sage
Victor Sage
21 Oct 2026
xReality Group has identified unaudited adjustments that deepen its FY26 loss by $5.79 million and cut net assets from $14.0 million to $6.7 million. Customer revenue and cash flow are unchanged, but trading is suspended until the audit and amended accounts are completed.
Sophie Babbage
Sophie Babbage
1 Oct 2026
Papyrus Australia moved its banana-fibre technology into early commercialisation during FY26, signing an estimated $4.2 million TBS supply contract and delivering commercial-scale samples. But the company ended the year with $257,077 cash, negative equity and an auditor-flagged material uncertainty over its ability to continue as a going concern.
Victor Sage
Victor Sage
22 Sept 2026
EMVision has completed the first stage of a Melbourne Mobile Stroke Unit study, operating its portable brain scanner in homes, ambulances and a workplace. The small, non-diagnostic feasibility study produced strong usability results while pointing to a larger clinical validation step planned for next-generation units.
Victor Sage
Victor Sage
16 Sept 2026
ABx Group and its ALCORE subsidiary have received nearly $600,000 in R&D tax offsets, while ALCORE has completed repayment of $2.61 million in unused government grant funds. The company is now awaiting a decision on a separate Industry Growth Program application worth up to $5 million.
Victor Sage
Victor Sage
14 Sept 2026
EMVision Medical Devices has made significant strides in its emu™ bedside scanner pivotal trial and First Responder program, boosting FY26 revenue by 57% while trimming its net loss by 15%.
Ada Torres
Ada Torres
24 Aug 2026
The Calmer Co. has secured a long-term supply agreement for premium noble kava from Papua New Guinea and Vanuatu, underpinning its manufacturing growth and diversified Pacific sourcing network.
Victor Sage
Victor Sage
6 Aug 2026
EMVision Medical Devices has hit key enrolment milestones in its pivotal brain scanner trial, expanded clinical endpoints, and maintained a strong cash position with $17.1 million on hand.
Ada Torres
Ada Torres
15 July 2026
Cooks Coffee lifted UK and Ireland store sales 22.8% to NZ$95.8 million in FY26, with EBITDA up 14% to NZ$1.39 million. Despite operational growth and debt reduction, net liabilities and liquidity pressures raise material going concern doubts.
Eva Park
Eva Park
26 June 2026
Cooks Coffee posted a 22.8% jump in UK and Ireland store sales for FY26, driving a 27% lift in normalised EBITDA. The company confirmed new store openings in Dubai and India, signalling a push into fast-growing international markets.
Victor Sage
Victor Sage
25 June 2026

Browse the archive

Full archive